Fortress Net Income from 2010 to 2026
| FBIO Stock | USD 3.27 0.34 11.60% |
Net Loss | First Reported 2009-12-31 | Previous Quarter 15.5 M | Current Value 5.8 M | Quarterly Volatility 8.5 M |
Check Fortress Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fortress Biotech's main balance sheet or income statement drivers, such as Interest Expense of 7 M, Other Operating Expenses of 124.4 M or Research Development of 56.6 M, as well as many indicators such as Price To Sales Ratio of 0.8, Dividend Yield of 0.0776 or PTB Ratio of 2.03. Fortress financial statements analysis is a perfect complement when working with Fortress Biotech Valuation or Volatility modules.
Fortress | Net Income | Build AI portfolio with Fortress Stock |
Evaluating Fortress Biotech's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Fortress Biotech's fundamental strength.
Latest Fortress Biotech's Net Income Growth Pattern
Below is the plot of the Net Income of Fortress Biotech over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Fortress Biotech financial statement analysis. It represents the amount of money remaining after all of Fortress Biotech operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Fortress Biotech's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fortress Biotech's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (120.86 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Fortress Net Income Regression Statistics
| Arithmetic Mean | (47,595,321) | |
| Coefficient Of Variation | (44.44) | |
| Mean Deviation | 15,681,618 | |
| Median | (45,997,000) | |
| Standard Deviation | 21,150,459 | |
| Sample Variance | 447.3T | |
| Range | 82.8M | |
| R-Value | (0.50) | |
| Mean Square Error | 359.1T | |
| R-Squared | 0.25 | |
| Significance | 0.04 | |
| Slope | (2,082,986) | |
| Total Sum of Squares | 7157.5T |
Fortress Net Income History
Other Fundumenentals of Fortress Biotech
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Fortress Biotech Net Income component correlations
About Fortress Biotech Financial Statements
Fortress Biotech investors utilize fundamental indicators, such as Net Income, to predict how Fortress Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -108.8 M | -114.2 M | |
| Net Loss | -108.8 M | -114.2 M | |
| Net Loss | -58.2 M | -61.1 M | |
| Net Loss | (1.99) | (2.09) | |
| Net Income Per E B T | 0.44 | 0.59 |
Pair Trading with Fortress Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fortress Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will appreciate offsetting losses from the drop in the long position's value.Moving against Fortress Stock
| 0.82 | IMRN | Immuron Ltd ADR | PairCorr |
| 0.65 | GNLX | Genelux Common | PairCorr |
| 0.63 | DWTX | Dogwood Therapeutics | PairCorr |
| 0.63 | EDIT | Editas Medicine | PairCorr |
| 0.52 | QSI | QuantumSi | PairCorr |
The ability to find closely correlated positions to Fortress Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fortress Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fortress Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fortress Biotech to buy it.
The correlation of Fortress Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fortress Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fortress Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fortress Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Fortress Biotech Correlation against competitors. To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Will Biotechnology sector continue expanding? Could Fortress diversify its offerings? Factors like these will boost the valuation of Fortress Biotech. Market participants price Fortress higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Fortress Biotech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.12) | Revenue Per Share | Quarterly Revenue Growth 0.205 | Return On Assets | Return On Equity |
Fortress Biotech's market price often diverges from its book value, the accounting figure shown on Fortress's balance sheet. Smart investors calculate Fortress Biotech's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Fortress Biotech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.